You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

limited disease small-cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)

Recruiting
  • Small Cell Lung Cancer Limited Stage
  • Löwenstein, Baden-Würtemberg, Germany
  • +9 more
May 18, 2022

Small Cell Lung Carcinoma Trial in Denmark, Norway, Sweden (45 Gy in 30 fractions, 60 Gy in 40 fractions)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • 45 Gy in 30 fractions
  • 60 Gy in 40 fractions
  • København, Denmark
  • +21 more
Sep 16, 2022

Small Cell Lung Carcinoma Trial in France (Durvalumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Aix-en-Provence, France
  • +35 more
Jan 16, 2023

NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess

Recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Local ablative therapy
  • Blood collection to assess for ctDNA
  • Basking Ridge, New Jersey
  • +6 more
Jun 20, 2022

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +

Recruiting
  • Limited Stage Small Cell Lung Cancer
  • Not Progressed After First-line Chemoradiotherapy
  • TQB2450 Injection + Anlotinib Hydrochloride Capsules
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong First Medical University
Jul 5, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Limited Stage Small Cell Lung Cancer Trial in Shang'ai (chemo and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy
  • Shang'ai, Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • (no location specified)
Jun 29, 2022

Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

Not yet recruiting
  • Lung Neoplasms
  • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
  • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
  • (no location specified)
Jun 12, 2023

Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

Not yet recruiting
  • Small Cell Lung Cancer Limited Stage
  • Prophylactic cranial irradiation
  • +2 more
  • (no location specified)
Dec 14, 2022

Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)

Completed
  • Lung Cancer
  • Once daily radiotherapy
  • Twice daily radiotherapy
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Sep 5, 2022

Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)

Recruiting
  • Limited Stage Small Cell Lung Cancer
  • Shanghai, Shanghai, China
  • +1 more
Jul 29, 2022

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

    Recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • +3 more
    • Biopsy
    • +4 more
    • Los Angeles, California
    • +8 more
    Jan 31, 2023

    Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)

    Active, not recruiting
    • Carcinoma, Small Cell Lung
    • Beijing City, China
    • +20 more
    Dec 15, 2022

    NSCLC Trial (V940, Pembrolizumab, Placebo)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • V940
    • +2 more
    • (no location specified)
    Oct 5, 2023

    NSCLC Trial in Shanghai (SI-B001, SI-B003)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    NSCLC Trial in Guangzhou (PLB1001)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 15, 2023

    ALK Positive NSCLC Trial in Guangzhou (Loratinib)

    Recruiting
    • ALK Positive Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial Perople's Hospital
    Oct 19, 2023

    Advanced NSCLC Trial in Jinan (almonertinib)

    Recruiting
    • Advanced Non-small Cell Lung Cancer
    • Jinan, Shandong, China
      Degan Lu
    Sep 12, 2023

    NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    May 25, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Sydney, New South Wales, Australia
    • +6 more
    Mar 21, 2023